Author details

Full Name

David R Booth

Affiliation

ORCID

Career Start Year

2003

Papers

113

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34952359	Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.	Journal of Autoimmunity	2022
35337467	The history of Salpingoeca rosetta as a model for reconstructing animal origins.	Current Topics in Developmental Biology	2022
34488019	The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.	eBioMedicine	2021
32229546	HBV vaccination and HBV infection induces HBV-specific natural killer cell memory.	Gut	2021
33805769	The Interaction of Human and miRNAs with Multiple Sclerosis Risk Loci.	International Journal of Molecular Sciences	2021
33541415	Age-dependent VDR peak DNA methylation as a mechanism for latitude-dependent multiple sclerosis risk.	Epigenetics and Chromatin	2021
34163021	Expression of CYP24A1 and other multiple sclerosis risk genes in peripheral blood indicates response to vitamin D in homeostatic and inflammatory conditions.	Genes and Immunity	2021
33828550	Immunophenotyping of Peripheral Blood Mononuclear Cells in Septic Shock Patients With High-Dimensional Flow Cytometry Analysis Reveals Two Subgroups With Differential Responses to Immunostimulant Drugs.	Front Immunol	2021
34566997	Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.	Frontiers in Immunology	2021
33079481	Vitamin D and its Effects on DNA Methylation in Development, Aging, and Disease.	Molecular Nutrition and Food Research	2020
31619767	Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions.	Genes and Immunity	2020
31932685	The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.	Scientific Reports	2020
33037402	Regulation of the methylome in differentiation from adult stem cells may underpin vitamin D risk in MS.	Genes and Immunity	2020
31003840	Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman.	Pathology	2019
31798594	Macrophage Coordination of the Interferon Lambda Immune Response.	Frontiers in Immunology	2019
30285234	The latitude-dependent autoimmune disease risk genes ZMIZ1 and IRF8 regulate mononuclear phagocytic cell differentiation in response to vitamin D.	Human Molecular Genetics	2019
31039804	Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.	Genome Medicine	2019
31138860	Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome.	Scientific Reports	2019
29780610	A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2018
30057580	Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome.	Frontiers in Immunology	2018
30128151	Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis.	Clinical and Translational Immunology	2018
29507931	Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.	JAMA Neurology	2018
29363187	GPR65 inhibits experimental autoimmune encephalomyelitis through CD4<sup>+</sup> T cell independent mechanisms that include effects on iNKT cells.	Immunol Cell Biol	2018
29239069	The antiviral role of zinc and metallothioneins in hepatitis C infection.	Journal of Viral Hepatitis	2018
28275670	Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis.	Data Brief	2017
28690849	Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis.	Clinical and Translational Immunology	2017
28458668	The Multiple Sclerosis (MS) Genetic Risk Factors Indicate both Acquired and Innate Immune Cell Subsets Contribute to MS Pathogenesis and Identify Novel Therapeutic Opportunities.	Frontiers in Immunology	2017
28619954	A novel immune biomarker <i>IFI27</i> discriminates between influenza and bacteria in patients with suspected respiratory infection.	Eur Respir J	2017
28617321	Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI.	International Journal of Molecular Sciences	2017
28513591	Zinc is a potent and specific inhibitor of IFN-Î»3 signalling.	Nature Communications	2017
28394349	IFN-Î»3, not IFN-Î»4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.	Nature Genetics	2017
28063629	The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis.	J Autoimmun	2017
28167940	Narrowband UVB Phototherapy for Clinically Isolated Syndrome: A Trial to Deliver the Benefits of Vitamin D and Other UVB-Induced Molecules.	Frontiers in Immunology	2017
26592354	FibroGENE: A gene-based model for staging liver fibrosis.	Journal of Hepatology	2016
28607721	Differences in common heritable blood immune cell populations may underlie MS susceptibility and progression.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2016
27387528	Transcriptional reprogramming of metabolic pathways in critically ill patients.	Intensive Care Med Exp	2016
26822232	Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.	Hepatology	2016
26986782	Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases.	Genes Immun	2016
27307212	IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection.	Genes and Immunity	2016
26762769	The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.	Clinical Immunology	2016
25214320	Impact of common risk factors of fibrosis progression in chronic hepatitis C.	Gut	2015
25703062	Resistance to hepatitis C virus: potential genetic and immunological determinants.	Lancet Infectious Diseases, The	2015
25740255	Interferon-Î» rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.	Nature Communications	2015
26313459	Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.	PLoS ONE	2015
26343388	Class II HLA interactions modulate genetic risk for multiple sclerosis.	Nat Genet	2015
26068105	The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function.	PLoS ONE	2015
25150865	Whole blood transcriptomic analysis to identify clinical biomarkers of drug response.	Methods in Molecular Biology	2014
25340056	Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.	Neurology: Neuroimmunology and NeuroInflammation	2014
25548481	Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.		2014
25364774	Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis.	Neurol Neuroimmunol Neuroinflamm	2014